Viewing Study NCT03843892


Ignite Creation Date: 2025-12-24 @ 3:40 PM
Ignite Modification Date: 2025-12-26 @ 8:35 PM
Study NCT ID: NCT03843892
Status: APPROVED_FOR_MARKETING
Last Update Posted: 2024-12-10
First Post: 2019-02-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Expanded Access Program to Provide Nintedanib to Patients With Non-IPF ILD Who Have no Alternative Treatment Possibilities
Sponsor: Boehringer Ingelheim
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module